Racial Disparities in the Management of Locoregional Colorectal Cancer

Scarlett Hao; Alexander A Parikh; Rebecca A Snyder

doi:10.1016/j.soc.2021.07.008

Racial Disparities in the Management of Locoregional Colorectal Cancer

Surg Oncol Clin N Am. 2022 Jan;31(1):65-79. doi: 10.1016/j.soc.2021.07.008. Epub 2021 Oct 19.

Authors

Scarlett Hao¹, Alexander A Parikh¹, Rebecca A Snyder²

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Brody School of Medicine at East Carolina University, 600 Moye Boulevard, Surgical Oncology Suite, 4S-24, Greenville, NC 27834, USA.
² Division of Surgical Oncology, Department of Surgery, Brody School of Medicine at East Carolina University, 600 Moye Boulevard, Surgical Oncology Suite, 4S-24, Greenville, NC 27834, USA. Electronic address: snyderre19@ecu.edu.

PMID: 34776065
DOI: 10.1016/j.soc.2021.07.008

Abstract

Racial disparities pervade nearly all aspects of management of locoregional colorectal cancer, including time to treatment, receipt of resection, adequacy of resection, postoperative complications, and receipt of neoadjuvant and adjuvant multimodality therapies. Disparate gaps in treatment translate into enduring effects on survivorship, recurrence, and mortality. Efforts to reduce these gaps in care must be undertaken on a multilevel basis and focus on modifiable factors that underlie racial disparity.

Keywords: Chemotherapy; Colorectal cancer; Disparities; Health policy; Neoadjuvant; Surgery.

Publication types

Review

MeSH terms

Colorectal Neoplasms* / surgery
Combined Modality Therapy
Humans
Neoadjuvant Therapy*